secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0000950170-21-003322
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences appoints Dara Richardson-Heron to board and Ruhi Khan as Chief Business Officer
--------------------------------------------------------------------------------

- Dara Richardson-Heron, M.D., appointed as Class III director effective Nov 4, 2021, and to Nominating Committee.
- Ruhi Khan appointed as Chief Business Officer, bringing 20+ years of biotech business development experience.
- Board size increased from six to seven directors to accommodate Richardson-Heron's appointment.
- Richardson-Heron receives standard director compensation: $40K/yr cash plus $4K/yr for committee; initial option for 44,000 shares vesting over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000095017021003322/0000950170-21-003322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000095017021003322/crbu-20211104.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-003322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer